More than 5 million people are diagnosed with skin cancer in the U.S. each year, and an overwhelming majority are categorized as either basal or cutaneous squamous cell carcinoma.

"Researchers have been studying the possible link between hair dye and cancer for a long time, but results have been inconsistent," said co-author Alexandra White, PhD.

Annual mammography screenings find cancer in patients at a less advanced stage than those who have a mammogram every two years, according to a new study presented at the annual meeting of the Radiological Society of North America.

Although 90% of those surveyed said they stand by their choice of treatment, one-third did not have enough information about the side effects of radiation, chemotherapy or surgery.

The updated guidelines suggest clinicians screen adults ages 50-75 who are at average risk for the disease, and discuss the benefits, harms and costs of the three screening methods prior to undertaking any one procedure.

A new AI algorithm developed by researchers at Case Western Reserve University can predict which malignant breast cancers will progress and benefit from additional treatment.

As of now the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has enrolled 16,505 participants across a number of certified mammography clinics in the U.S., Canada and Argentina, with more sites and participants to come.

“Because BI-RADS 3 breast lesions have up to 2% likelihood of malignancy, it is imperative that optimal follow-up of BI-RADS 3 test results be addressed...," authors of the new study published in JACR wrote.